paroxetine has been researched along with Chronic Illness in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (24.32) | 18.2507 |
| 2000's | 21 (56.76) | 29.6817 |
| 2010's | 7 (18.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liebl, C; Müller, MB; Scharf, SH; Schmidt, MV; Sterlemann, V | 1 |
| Garcia-Feijoo, J; Gonzelez-Romero, JC; Saenz-Frances, F; Santos-Bueso, E; Sierra-Rodriguez, MA | 1 |
| Bilici, S; Gor, AP; Taskin, U; Yigit, O; Yilmaz, ED | 1 |
| Weisshaar, E | 1 |
| Asarnow, JR; Birmaher, B; Brent, D; Clarke, G; DeBar, L; Emslie, G; Iyengar, S; Keller, M; Kennard, B; Leonard, H; Mayes, T; McCracken, J; Porta, G; Ritz, L; Ryan, N; Shamseddeen, W; Spirito, A; Strober, M; Suddath, R; Vitiello, B; Wagner, KD | 1 |
| Böckenholt, B; Heuft, G; Luger, TA; Schneider, G; Schürmeyer-Horst, F; Ständer, S; Weishaupt, C | 1 |
| Del Rio, J; Elizalde, N; García-García, AL; Gendive, N; Ramirez, MJ; Tordera, RM; Totterdell, S; Venzala, E | 1 |
| Alesci, S; Bonne, O; Charney, DS; Collins, C; Gill, JM; Kinkead, B; Luckenbaugh, DA; Manji, HK; Neumeister, A; Owens, MJ; Vythilingam, M; Yuan, P | 1 |
| Khasanov, NR; Khasanova, DR; Oslopov, VN; Safiullina, AA; Zhitkova, IuV | 1 |
| Denys, D; Figee, M; Olff, M; Opmeer, BC; Polak, AR; Visser, RS; Vulink, N; Witteveen, AB | 1 |
| Christensen, J; Clemmensen, PM; Dalsgaard, NJ; Dam, H; Hindberg, I; Lunde, M; Mellerup, E; Plenge, P; Rasmussen, A | 1 |
| Akiyoshi, J; Fujiki, M; Horinouchi, Y; Isogawa, K; Kodama, K; Nagayama, H; Tsutsumi, T | 1 |
| Cordingley, GE; Holroyd, KA; Labus, JS; O'Donnell, FJ | 1 |
| Aizawa, Y; Fujita, S; Hanawa, H; Hayashi, M; Kato, K; Kodama, M; Komura, S; Kondo, D; Minagawa, S; Ohno, Y; Okura, Y; Sato, A | 1 |
| Bauer, A; Godemann, F; Jockers-Scherübl, MC; Reischies, FM; Schlattmann, P; Selig, F | 1 |
| Lang, AE; Voon, V | 1 |
| Kubota, T; Miyata, A | 1 |
| Blanco, C; Garcia, W; Lewis-Fernandez, R; Liebowitz, MR; Lin, SH; Marshall, RD; Neria, Y; Sanchez-Lacay, A; Schneier, F; Simpson, HB; Vermes, D | 1 |
| Buysse, DJ; Hall, M; Mazumdar, S; Miller, MD; Pollock, BG; Reynolds, CF | 1 |
| Alam, S; Ganea, K; Greetfeld, M; Harbich, D; Holsboer, F; Liebl, C; Müller, MB; Schmidt, MV; Sterlemann, V; Uhr, M | 1 |
| Cines, M; Gottlieb, SS; Greenberg, N; Katzen, S; Kop, WJ; Marshall, J; Minshall, S; Thomas, SA; Vesely, MR | 1 |
| Nagata, T; Nakayama, K; Ono, K | 1 |
| Altunayoglu, V; Boz, C; Gazioglu, S; Hocaoglu, C | 1 |
| Bereza, BG; Einarson, TR; Iskedjian, M; Le Melledo, JM; Walker, JH | 1 |
| Eriksen, J; Jensen, NH; Lauritzen, L; Lunde, M; Mellerup, ET; Plenge, P | 1 |
| Bach, FW; Ekman, R; Langemark, M; Olesen, J; Rehfeld, JF; Schifter, S | 1 |
| Stokes, PE | 1 |
| Langemark, M; Olesen, J | 1 |
| Kupfer, DJ | 1 |
| Green, AI; Patel, JK; Salzman, C; Tsuang, MT | 1 |
| Poirier, MF | 1 |
| Abramson, I; Atkinson, JH; Epping-Jordan, JE; Garfin, SR; Grant, I; Patterson, TL; Pruitt, SD; Slater, MA; Wahlgren, DR; Williams, RA; Zisook, S | 1 |
| Blanchard, DC; Blanchard, RJ; Magariños, AM; McEwen, BS; McKittrick, CR; Sakai, RR | 1 |
| Godemann, F; Jockers-Scherübl, M; Pietzcker, A | 1 |
| Beebe, KL; Marshall, RD; Oldham, M; Zaninelli, R | 1 |
| Dillingham, K; Pitts, CD; Ruggiero, L; Tucker, P; Yehuda, R; Zaninelli, R | 1 |
3 review(s) available for paroxetine and Chronic Illness
| Article | Year |
|---|---|
Current issues in the treatment of major depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Bipolar Disorder; Chronic Disease; Clinical Trials as Topic; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Incidence; Male; Middle Aged; Paroxetine; United States | 1993 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
The management of chronic pain in patients with breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Society of Palliative Care Physicians. Canadian Association of Radiation Oncologist
Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents; Breast Neoplasms; Chronic Disease; Female; Humans; Morphine; Pain; Pain Measurement; Paroxetine; Professional Staff Committees; Severity of Illness Index | 1998 |
19 trial(s) available for paroxetine and Chronic Illness
| Article | Year |
|---|---|
Chronic social stress during adolescence: interplay of paroxetine treatment and ageing.
Topics: Adrenal Glands; Aging; Animals; Arginine Vasopressin; Body Weight; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Longitudinal Studies; Male; Mice; Paroxetine; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Social Isolation; Stress, Psychological; Thymus Gland | 2013 |
Medium-term results of combined treatment with transcranial magnetic stimulation and antidepressant drug for chronic tinnitus.
Topics: Adult; Antidepressive Agents, Second-Generation; Auditory Cortex; Chronic Disease; Combined Modality Therapy; Double-Blind Method; Emotions; Female; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tinnitus; Transcranial Magnetic Stimulation; Young Adult | 2015 |
Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Personality Inventory; Prognosis; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Comparison of the effectiveness of trauma-focused cognitive behavioral therapy and paroxetine treatment in PTSD patients: design of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Humans; Middle Aged; Paroxetine; Research Design; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2012 |
Platelet serotonin transporter in stroke patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Binding, Competitive; Biomarkers; Blood Platelets; Carrier Proteins; Chronic Disease; Depression; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; Serotonin Plasma Membrane Transport Proteins; Stroke; Time Factors | 2003 |
Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation.
Topics: Adult; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Chronic Disease; Double-Blind Method; Female; Humans; Male; Paroxetine; Pilot Projects; Serotonin Receptor Agonists; Tension-Type Headache; Treatment Failure | 2003 |
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2005 |
Antidepressant treatment outcomes of psychogenic movement disorder.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; Comorbidity; Conversion Disorder; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypochondriasis; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.
Topics: Adult; Antidepressive Agents, Second-Generation; Black People; Chronic Disease; Dissociative Disorders; Double-Blind Method; Female; Follow-Up Studies; Hispanic or Latino; Humans; Interpersonal Relations; Male; Middle Aged; Paroxetine; Personality Assessment; Stress Disorders, Post-Traumatic; Urban Population; White People | 2007 |
Paroxetine treatment of primary insomnia in older adults.
Topics: Aged; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Failure | 2006 |
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Delayed-Action Preparations; Depression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Treatment Outcome | 2007 |
Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
Topics: Adult; Character; Chronic Disease; Citalopram; Female; Fluoxetine; Harm Reduction; Humans; Internal-External Control; Male; Paroxetine; Personal Autonomy; Personality Inventory; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Temperament; Tension-Type Headache | 2007 |
Effect of sulpiride or paroxetine on cerebrospinal fluid neuropeptide concentrations in patients with chronic tension-type headache.
Topics: Adult; Aged; Basal Metabolism; Calcitonin Gene-Related Peptide; Cholecystokinin; Chronic Disease; Dopamine D2 Receptor Antagonists; Dynorphins; Female; Humans; Male; Middle Aged; Neuropeptides; Paroxetine; Somatostatin; Sulpiride; Tension-Type Headache | 1994 |
Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Muscle Contraction; Paroxetine; Pilot Projects; Sulpiride | 1994 |
[The concept of resistant depression and therapeutic strategies, particularly, with venlafaxine].
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Humans; Paroxetine; Remission, Spontaneous; Severity of Illness Index; Venlafaxine Hydrochloride | 1999 |
Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Chronic Disease; Diphenhydramine; Double-Blind Method; Humans; Hypnotics and Sedatives; Low Back Pain; Maprotiline; Middle Aged; Pain Measurement; Paroxetine; Patient Selection; Placebos; Selective Serotonin Reuptake Inhibitors | 1999 |
Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personality Assessment; Sex Factors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2001 |
Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.
Topics: Adolescent; Adult; Aged; Chronic Disease; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2001 |
15 other study(ies) available for paroxetine and Chronic Illness
| Article | Year |
|---|---|
Chronic angle-closure glaucoma related to paroxetine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iridectomy; Lasers, Solid-State; Paroxetine; Vision, Low; Visual Acuity | 2013 |
Intractable chronic pruritus in a 67-year-old man.
Topics: Adenocarcinoma; Aged; Chronic Disease; Humans; Male; Paraneoplastic Syndromes; Paroxetine; Prostatic Neoplasms; Pruritus; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2008 |
Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chronic Disease; Dermatitis, Atopic; Female; Fluvoxamine; Humans; Lymphoma; Male; Middle Aged; Paroxetine; Prospective Studies; Pruritus; Selective Serotonin Reuptake Inhibitors | 2009 |
Sustained stress-induced changes in mice as a model for chronic depression.
Topics: Animals; Cell Proliferation; Chronic Disease; Depressive Disorder, Major; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Paroxetine; Stress, Psychological; Time Factors | 2010 |
Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Chronic Disease; Corticotropin-Releasing Hormone; Female; Humans; Insulin-Like Growth Factor I; Interleukin-6; Male; Middle Aged; Paroxetine; Personality Inventory; Psychometrics; Stress Disorders, Post-Traumatic; Substance P; Treatment Outcome | 2011 |
[Efficacy of adepress (paroxetine) in the treatment of depression in patients with chronic cerebral ischemia in the late recovery phase of ischemic stroke with the estimation of the velocity of passive transmembrane ion transport].
Topics: Aged; Antidepressive Agents, Second-Generation; Brain Ischemia; Chronic Disease; Cognition; Depression; Erythrocyte Membrane; Female; Humans; Ion Transport; Lithium; Male; Middle Aged; Paroxetine; Sodium; Treatment Outcome | 2012 |
Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats.
Topics: Acute Disease; Animals; Anxiety; Chronic Disease; Electric Stimulation; Fear; Male; Maze Learning; Motor Activity; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Transcranial Magnetic Stimulation | 2003 |
Life-threatening serotonin syndrome in a patient with chronic heart failure and CYP2D6*1/*5.
Topics: Adult; Chronic Disease; Cytochrome P-450 CYP2D6; Diagnosis, Differential; Electrocardiography; Heart Failure; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2004 |
Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Electrolytes; Humans; Hyponatremia; Inappropriate ADH Syndrome; Intervertebral Disc Displacement; Male; Pain; Paroxetine; Sodium; Spinal Stenosis; Vasopressins | 2006 |
Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence.
Topics: Adaptation, Physiological; Adaptation, Psychological; Adrenal Glands; Adrenocorticotropic Hormone; Age Factors; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Chronic Disease; Corticosterone; Disease Models, Animal; Exploratory Behavior; Hierarchy, Social; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mice; Paroxetine; Pituitary-Adrenal System; Receptors, Steroid; Social Behavior; Stress, Psychological | 2007 |
Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.
Topics: Anorexia Nervosa; Antidepressive Agents, Second-Generation; Benzodiazepines; Body Weight; Bulimia; Chronic Disease; Female; Hospitalization; Humans; Mianserin; Middle Aged; Olanzapine; Paroxetine; Schizotypal Personality Disorder; Selective Serotonin Reuptake Inhibitors | 2007 |
Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Canada; Chronic Disease; Citalopram; Confidence Intervals; Cost of Illness; Cost Savings; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Monte Carlo Method; Paroxetine; Primary Health Care; Sensitivity and Specificity; Severity of Illness Index | 2008 |
Platelet paroxetine binding in depressed and nondepressed chronic pain patients.
Topics: Adult; Aged; Biomarkers; Chronic Disease; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Paroxetine; Receptors, Serotonin | 1994 |
Chronic schizophrenia: response to clozapine, risperidone, and paroxetine.
Topics: Chronic Disease; Clozapine; Drug Therapy, Combination; Humans; Middle Aged; Paroxetine; Risperidone; Schizophrenia | 1997 |
Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites.
Topics: Animals; Binding Sites; Body Weight; Carrier Proteins; Cell Size; Chronic Disease; Corticosterone; Dendrites; Female; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Pyramidal Cells; Radioligand Assay; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological | 2000 |